Pediatric Endocrinology Diabetes and Metabolism
en POLSKI
eISSN: 2083-8441
ISSN: 2081-237X
Pediatric Endocrinology Diabetes and Metabolism
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees

Journal integrated with

integrated with publons
Share:
Send email
Share:
Review paper

Dysmorphic syndromes with overgrowth – systematic review, part 2: chromosomal and epigenetic disorders and disorders associated with dynamic mutations

Julia Klaudia Gąsiorowska
1
,
Amelia Grundys
1
,
Laura Gawlik
1
,
Weronika Dziamara
1
,
Robert Stanisław Śmigiel
2
,
Beata Wikiera
2

  1. Faculty of Medicine, Wroclaw Medical University, Polska
  2. Department of Paediatrics, Endocrinology, Diabetology and Metabolic Diseases, Wroclaw Medical University, Polska
Pediatr Endocrinol Diabetes Metab 2026; 32
DOI: https://doi.org/10.5114/pedm.2026.159968
Online publish date: 2026/03/27
Article file
- 0418_Dysmorphic syndromes.pdf  [1.61 MB]
Get citation
 
PlumX metrics:
 
1. Śmigiel R, Szczałuba K, Krajewska-Walasek M. Dysmorfologia w praktyce pediatrycznej. Wrocław: Katedra i Zakład Genetyki Uniwersytetu Medycznego; Białystok: Poradnia Genetyczna Mastermed; Warszawa: Zakład Genetyki Medycznej, Instytut "Pomnik-Centrum Zdrowia Dziecka"; 2013. Standardy Medyczne. Pediatria. 10: 219–227.
2. Cerrolaza JJ, Porras AR, Mansoor A, et al. Identification of dysmorphic syndromes using landmark-specific local texture descriptors. Proc Int Symp Biomed Imaging 2016; 2016: 1080–1083. doi: 10.1109/ISBI.2016.7493453.
3. Borowiec A, Sarwińska M, Pyrżak BE. Zaburzenia wzrastania u dziecka – od pediatry do endokrynologa. Forum Pediatr Prakt 2018. Available from: https://forumpediatrii.pl/artykul/zaburzenia-wzrastania-u-dziecka-od-pediatry-do-endokrynologa.
4. Verge CF, Mowat D. Overgrowth. Arch Dis Child 2010; 95: 458–463. doi: 10.1136/adc.2009.157693.
5. Fischer M, Klopocki E. Atypical 22q11.2 microduplication with “typical” signs and overgrowth. Cytogenet Genome Res 2020; 160: 659–663. doi: 10.1159/000512486.
6. Moschella A, Capra AP, Corica D, et al. A novel case of 16q22.3 duplication syndrome in a child with overgrowth: case report and literature review. BMC Med Genomics 2023; 16: 315. doi: 10.1186/s12920-023-01716-3.
7. Franke M, Daly AF, Palmeira L, et al. Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism. Am J Hum Genet 2022; 109: 553–570. doi: 10.1016/j.ajhg.2022.02.002.
8. Devys D, Lutz Y, Rouyer N, et al. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 1993; 4: 335–340. doi: 10.1038/ng0893-335.
9. Jacquemont S, Hagerman RJ, Hagerman PJ, et al. Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1. Lancet Neurol 2007; 6: 45–55. doi: 10.1016/S1474-4422(06)70676-7.
10. Fragile X syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025 [cited 4 Aug 2025]. Available from: https://www.ncbi.nlm.nih.gov/sites/books/NBK459243/.
11. Loesch DZ, Hay DA. Clinical features and reproductive patterns in fragile X female heterozygotes. J Med Genet 1988; 25: 407–414. doi: 10.1136/jmg.25.6.407.
12. Ho HZ, Glahn TJ, Ho JC. The fragile-X syndrome. Dev Med Child Neurol 1988; 30: 257–261. doi: 10.1111/j.1469-8749.1988.tb04760.x.
13. Mattei JF, Mattei MG, et al. X-linked mental retardation with the fragile X. A study of 15 families. Hum Genet 1981; 59: 281–289. doi: 10.1007/BF00295459.
14. Limprasert P, Jaruratanasirikul S. Unilateral macroorchidism in fragile X syndrome. Am J Med Genet 2000; 95: 516–517.
15. Moro F, Pisano T, Bernardina BD, et al. Periventricular heterotopia in fragile X syndrome. Neurology 2006; 67: 713–715. doi: 10.1212/01.wnl.0000230223.51595.99.
16. Gothelf D, Furfaro JA, et al. Neuroanatomy of fragile X syndrome is associated with aberrant behavior and the fragile X mental retardation protein (FMRP). Ann Neurol 2008; 63: 40–51. doi: 10.1002/ana.21243.
17. Berry-Kravis E, Levin R, Shah H, et al. Cholesterol levels in fragile X syndrome. Am J Med Genet A 2015; 167: 379–384. doi: 10.1002/ajmg.a.36850.
18. Rousseau F, Heitz D, Biancalana V, et al. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Engl J Med 1991; 325: 1673–1681.
19. Snow K, Doud LK, Hagerman R, et al. Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. Am J Hum Genet 1993; 53: 1217–1228.
20. Jenkins EC, Brown WT, et al. Feasibility of fragile X chromosome prenatal diagnosis demonstrated. Lancet 1981; 2: 1292.
21. Protic DD, Aishworiya R, Salcedo-Arellano MJ, et al. Fragile X syndrome: from molecular aspect to clinical treatment. Int J Mol Sci 2022; 23. doi: 10.3390/ijms23041935.
22. Pallister–Killian syndrome. Orphanet [cited 31 May 2025]. Available from: https://www.orpha.net/en/disease/detail/884.
23. Wu X, Xie X, Su L, et al. Prenatal diagnosis of Pallister–Killian syndrome and literature review. J Cell Mol Med 2021; 25: 8929–8935. doi: 10.1111/jcmm.16853.
24. Srinivasan A, Wright D. Pallister–Killian syndrome. Am J Case Rep 2014; 15: 194–198. doi: 10.12659/AJCR.890614.
25. Cohen MM Jr. Overgrowth syndromes. New York: Oxford University Press; 2002.
26. Segel R, Peter I, Demmer LA, et al. The natural history of trisomy 12p. Am J Med Genet A 2006; 140: 695–703. doi: 10.1002/ajmg.a.31143.
27. Hemihyperplasia. OMIM [cited 24 Mar 2025]. Available from: https://www.omim.org/entry/235000.
28. Vaiman M, Shilco P, Roitblat Y, et al. Hemihyperplasia/hemihypertrophy in adolescents: prospective international study. Int J Adolesc Med Health 2019; 33. doi: 10.1515/ijamh-2018-0066.
29. Shuman C, Kalish JM, Weksberg R. Beckwith–Wiedemann syndrome. In: GeneReviews. Seattle (WA): University of Washington; 2023.
30. Dalal AB, Phadke SR, Pradhan M, et al. Hemihyperplasia syndromes. Indian J Pediatr 2006; 73: 609–615. doi: 10.1007/BF02759927.
31. Craiglow BG, Ko CJ, Antaya RJ. Two cases of hemihyperplasia-multiple lipomatosis syndrome and review of asymmetric hemihyperplasia syndromes. Pediatr Dermatol 2014; 31: 507–510. doi: 10.1111/pde.12071.
32. Hemihyperplasia-multiple lipomatosis syndrome. Pharos [cited 24 Mar 2025]. Available from: https://pharos.nih.gov/diseases/hemihyperplasia-multiple%20lipomatosis%20syndrome.
33. Keppler-Noreuil KM, Rios JJ, Parker VER, et al. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A 2015; 167: 287–295. doi: 10.1002/ajmg.a.36836.
34. Hemihyperplasia-multiple lipomatosis syndrome. Genetic and Rare Diseases Information Center [cited 24 Mar 2025]. Available from: https://rarediseases.info.nih.gov/diseases/21051/hemihyperplasia-multiple-lipomatosis-syndrome.
35. Boybeyi Ö, Alanay Y, Kayikçioğlu A, Karnak I. Hemihyperplasia-multiple lipomatosis syndrome: an underdiagnosed entity in children with asymmetric overgrowth. J Pediatr Surg 2010; 45: E19-23. doi: 10.1016/j.jpedsurg.2009.10.059.
36. Hennekam RCM, Allanson JE, Krantz ID. Gorlin’s syndromes of the head and neck. New York: Oxford University Press; 2010.


Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2026 Termedia Sp. z o.o.
Developed by Termedia.